Log In
BCIQ
Print this Print this
 

ZYDPLA1

  Manage Alerts
Collapse Summary General Information
Company Zydus Cadila Group
DescriptionOnce-weekly dipeptidyl peptidase-4 (DPP-4; CD26) inhibitor
Molecular Target Dipeptidyl peptidase-4 (DPP-4) (CD26)
Mechanism of ActionDipeptidyl peptidase-4 (DPP-4) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today